FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Veterans of the Navy have high lung cancer rates associated with asbestos use.

2.

Many women undergo annual mammography, despite biennial screening recommendations

3.

Ketamine plus psychotherapy for "excellent" PTSD

4.

Study looks into cancer-related harmful communication.

5.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot